Mesto preparata Nolodatak v lechenii boli v spine


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

In recent years, the number of visits of patients with back pain and neck pain in health care institutions increased significantly. In most cases, back pain is caused by nonspecific degenerative changes in musculoskeletal system (spondylarthritis, osteoarthritis, osteochondrosis). Fundamentally new class of drugs for the treatment of pain syndromes, including back pain, is selective neuronal potassium channel openers - SNEPCO. One of representatives of this class of drugs is flupirtine (Nolodatak) - non-opioid analgesic that has antispastic effect on striated muscles.

Full Text

Restricted Access

About the authors

O. V Kotova

Email: ol_kotova@mail.ru

E. S Akarachkova

References

  1. Martin B., Turner J., Mirza S., Lee M.J., Comstock B.A., Deyo R.A. Trends in health care expenditures, utilization, and health status among US adults with spine problems. Spine (Phila Pa 1976). 2009;34:2077-84.
  2. Murray C., Atkinson C., Bhalla K.; US Burden of Disease Collaborators.The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310:591-608.
  3. Davis M., Yakusheva O., Gottlieb D., Bynum J. Regional Supply of Chiropractic Care and Visits to Primary Care Physicians forBackand NeckPain. J. Am. Board Fam. Med. 2015;28(4):481-90.
  4. Hart L., Deyo R., Cherkin D. Physician office visits for low back pain. Frequency, clinical evaluation, and treatment patterns from a U.S. national survey. Spine (Phila Pa 1976). 1995; 20:11-9.
  5. Velasco Garrido M., Bittner C., Harth V., Preis-ser A. Health status and health-related quality of life of municipal waste collection workers - a cross-sectional survey. J. Occup. Med. Toxicol. 2015;8:10-22.
  6. Котова О.В. Острая боль в нижней части спины: не дать болезни затянуться. Фарматека. 2012;14(247):60-4.
  7. Ueberall M., Mueller-Schwefe G., Terhaag B. Efficacy and tolerability of flupirtine in subacute/ chronic musculoskeletal pain - results of a patient level, pooled re-analysis of randomized, double-blind, controlled trials. Int. J. Clin. Pharmacol. Ther. 2011;49:637-47.
  8. Perovic S., Pialoglou P., Schroder H. C., Pergande G., Muller W.E. Flupirtine increases the levels of glutathione and Bc1-2 in hNT (human Ntera/ D1) neurons: mode of action of the drug-mediated anti-apoptotic effect. Eur. J. Pharmacol. 1996;12:157-64.
  9. Jakob R., Krieglsteinet J. Influence of flupir-tine on a G-protein coupled inwardly rectifying potassium current in hippocampal neurons. Br. J. Pharmacol. 1997;122:1333-38.
  10. Weiser T., Szelenyi I., Nickel B., Weinrich M. In vitro and in vivo findings about the muscle relaxing properties of flupirine. Naunyn-Schmiedeberg's Arch. Pharmacol. 1992;246;22-5.
  11. Wörz R., Müller-Schwefe G., Stroehmann I., Zeuner L., Zieglgansberger W., Zimmermann M. Back pain: Guidelines for drug therapy. Fortschr. Med. 2000;142(5):27-33. валентен оригинальному флупирти-ну (капсулы 100 мг, Плива Краков, Фармацевтический завод А.О., Польша), а в производстве Нолодатака использована субстанция компании Ролабо Аутсорсинг С.Л. (Испания).
  12. Herrmann W., Hiersemenzel R., Aigner M., Lobisch M., Riethmüller-Winzen H., Michel I. Long-term tolerance of flupirtine. Open multicenter study over one year. Fortschr. Med. 1993;111(15):266-70.
  13. Mueller-Schwefe G. Flupertine in acute and chronic pain associated with Muscle tenseness. Results of a postmarketing surveillance study. Forschr. Med. 2003;121:3-10.
  14. Worz R., Bolten W., Heller B., Krainick J.U., Pergande G. Flupirtine in comparison with ehlomiezanone in chronic musculoskeletal back pain. Results of a multicenter randomized doubleblind study. Fortschr. Med. 1996;114(35-36):500-04.
  15. Muller-Schwefe G., Uberall M. Analgesic and muscle tonus normalizing effect of flupir-tine retard in chronic back pain. Result of a standardized therapeutic evaluation applying objective methods for measuring pain pressure threshold, pain pressure tolerance and muscle tension. MMW Fortschr. Med. 2008; 4:153-61.
  16. Singal R., Gupta P., Jain N., Gupta S. Role of flupirtine in the treatment of pain - chemistry and its effects. Maedica (Buchar). 2012; 7(2):163-66.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2015 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies